Journals / Erciyes Medical Journal / 2018 / Cilt: 40 - Sayı: 4

Predictive Significance of Preoperative Neutrophil to Lymphocyte Ratio versus Platelet to Lymphocyte Ratio for Gleason Score in Prostate Cancer Patients

Pages
228–233
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, PLR levels were not a significant predictor of higher Gleason scores.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Inflammation plays a critical role in the development and progression of cancer.
📊
Key Findings & Data:Materials and Methods: A total of 173 patients with prostate cancer (mean age, 63±6.2 years) who underwent radical prostatectomy were included into this retrospective study.
💡
Conclusion & Impact:However, PLR levels were not a significant predictor of higher Gleason scores.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Inflammation plays a critical role in the development and progression of cancer. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are easily accessible basic inflammatory parameters. In this study, we aimed to analyze the association between the NLR, PLR, and the Gleason score in prostate cancer, which is main parameter used in the prostate cancer prognosis. Materials and Methods: A total of 173 patients with prostate cancer (mean age, 63±6.2 years) who underwent radical prostatectomy were included into this retrospective study. The NLR and PLR were derived from the complete blood cell count results from the preoperative period. Patients were divided into two groups, as the low grade prostate cancer (Gleason score≤7 [3+4]) and the high-grade prostate cancer (Gleason score≥7 [4+3]) group. A logistic regression analysis was performed to determine the association. Results: A univariate logistic regression analysis showed that the Ln-prostate specific antigen (PSA) (1.83, 95% confidence interval [CI] [1.01, 3.3] p=0.04), Ln-lymphocyte (0.38, 95% CI [0.15, 0.94] p=0.03), and Ln-NLR (1.9, 95% CI 1.9 [1.13, 3.38] p=0.01) levels were significantly associated with the high-grade Gleason score. However, the Ln-PLR levels revealed the association with marginal statistical significance (2.06, 95 % CI [0.95, 4.4] p=0.06). In multiple analyses, after adjusting the analysis for age, Ln-NLR (1.96, 95% CI [1.12, 3.42] p=0.01) and Ln-lymphocyte levels (0.38, 95% CI [0.15, 0.97] p=0.04) were still statistically significantly associated with high-grade prostate cancer. Conclusion: Higher NLR levels were significantly associated with high-grade prostate cancer. However, PLR levels were not a significant predictor of higher Gleason scores.

🔖

Cite This Article

ERGİN, G., KÖPRÜ, B., KIRAÇ, M., KİBAR, Y., BİRİ, H. (2018). Predictive Significance of Preoperative Neutrophil to Lymphocyte Ratio versus Platelet to Lymphocyte Ratio for Gleason Score in Prostate Cancer Patients. Erciyes Medical Journal, Cilt: 40 - Sayı: 4, 228–233. https://ajindex.com/articles/192524

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62(1): 10-29. [CrossRef] Eser S, Zorlu F, Divtik RT, Cal C, Ozkan M, Kirkali Z. Incidence and epidemiological features of cancers of the genitourinary tract in Izmir between 1993-2002. Asian Pac J Cancer Prev 2009; 10(3): 491-6.
  2. Zorlu F, Zorlu R, Divrik RT, Eser S, Yorukoglu K. Prostate cancer incidence in Turkey: an epidemiological study. Asian Pac J Cancer Prev 2014; 15(21): 9125-930. [CrossRef] De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, Drake CG. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7(4): 256-69. [CrossRef] 5. Stark T, Livas L, Kyprianou N. Inflammation in prostate cancer progression and therapeutic targeting. Transl Androl Urol 2015; 4(4): 455-63.
  3. Sundar S, O’Cathail M. Neutrophil-lymphocyte ratio is prognostic but not predictive of response to Abiraterone in metastatic castration-resistant prostate cancer. JRSM Open 2015; 6(12): doi: 10.1177/2054270415611332 [CrossRef] Jin Y, Ye X, He C, Zhang B, Zhang Y. Pretreatment neutrophilto-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma. Head Neck 2015; 37(1): 6975. [CrossRef] Zhang GM, Zhu Y, Gu WJ, Zhang HL, Shi GH, Ye DW. Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy. Int J Clin Oncol 2016; 21(2): 373-8. [CrossRef] Sun W, Zhang L, Luo M, Hu G, Mei Q, Liu D, et al. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Head Neck 2016; 38 Suppl 1: E1332-40. [CrossRef] Wang Y, Xu F, Pan J, Zhu Y, Shao X, Sha J, et al. Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy. BMC Cancer 2016; 16: 329. [CrossRef] Kaynar M, Yildirim ME, Gul M, Kilic O, Ceylan K, Goktas S. Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio. Cancer Biomark 2015; 15(3): 317-23. [CrossRef] Yuksel OH, Urkmez A, Akan S, Yldirim C, Verit A. Predictive Value of the Platelet-To-Lymphocyte Ratio in Diagnosis of Prostate Cancer. Asian Pac J Cancer Prev 2015; 16(15): 6407-12. [CrossRef] Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL, Committee IG. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Car